Medicare Part B Drug Payment Controls To Be Evaluated By CMS
CMS will explore whether drug claims edits, medical reviews imposed by Medicare contractors help reduce improper payments, HHS Office of Inspector General says.
You may also be interested in...
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’
Center for American Progress suggests pricing reforms for the 'next Administration' in lieu of legislation.
Effectiveness can be evaluated more quickly because researchers won’t have to wait for the second dose, company executive notes during briefing on the launch of the Phase III study.